Bay98-7196, Dose Finding / POC Study
Public ClinicalTrials.gov record NCT02203331. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind, Double-dummy, Parallel- Group, Multi-center Phase IIb Study to Assess the Efficacy and Safety of Different Dose Combinations of an Aromatase Inhibitor and a Progestin in an Intravaginal Ring Versus Placebo and Leuprorelin / Leuprolide Acetate in Women With Symptomatic Endometriosis Over a 12-week Treatment Period
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Purpose of the study is to test efficacy and safety of BAY98-7196 intravaginal ring as a new treatment option for patients with endometriosis-associated pelvic pain
Study identification
- NCT ID
- NCT02203331
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 319 participants
Conditions and interventions
Conditions
Interventions
- Placebo Drug
- Levonorgestrel Drug
- Anastrozole Drug
- Lupron / Leuprolide acetate Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 16, 2014 (Actual)
- Primary completion
- Oct 24, 2016 (Actual)
- Completion
- Oct 24, 2016 (Actual)
- Last update posted
- Nov 7, 2023
2014 – 2016
United States locations
- U.S. sites
- 25
- U.S. states
- 15
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | San Diego | California | 92108 | — |
| Not listed | San Francisco | California | 94158-2509 | — |
| Not listed | Gainesville | Florida | 32605 | — |
| Not listed | New Port Richey | Florida | 34652 | — |
| Not listed | Atlanta | Georgia | 30338 | — |
| Not listed | Sandy Springs | Georgia | 30328 | — |
| Not listed | Chicago | Illinois | 60611 | — |
| Not listed | Palos Heights | Illinois | 60463 | — |
| Not listed | Wichita | Kansas | 67226 | — |
| Not listed | Marrero | Louisiana | 70072 | — |
| Not listed | Canton | Michigan | 48187 | — |
| Not listed | Detroit | Michigan | 48034 | — |
| Not listed | Saginaw | Michigan | 48604 | — |
| Not listed | Lincoln | Nebraska | 68510 | — |
| Not listed | Neptune City | New Jersey | 07754 | — |
| Not listed | Plainsboro | New Jersey | 08536 | — |
| Not listed | Durham | North Carolina | 27713 | — |
| Not listed | Greensboro | North Carolina | 27408 | — |
| Not listed | Winston-Salem | North Carolina | 27103 | — |
| Not listed | Columbus | Ohio | 43213 | — |
| Not listed | Dayton | Ohio | 45409 | — |
| Not listed | Philadelphia | Pennsylvania | 19104 | — |
| Not listed | Chattanooga | Tennessee | 37404 | — |
| Not listed | Seattle | Washington | 98105 | — |
| Not listed | Madison | Wisconsin | 53562 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 92 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02203331, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 7, 2023 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02203331 live on ClinicalTrials.gov.